Susquehanna International Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,900
Closed -$3K 14211
2022
Q3
$3K Sell
17,900
-183,600
-91% -$98.8K ﹤0.01% 12936
2022
Q2
$357K Sell
201,500
-60,300
-23% -$135K ﹤0.01% 9090
2022
Q1
$788K Buy
261,800
+155,300
+146% +$416K ﹤0.01% 7760
2021
Q4
$396K Buy
106,500
+55,900
+110% +$327K ﹤0.01% 9810
2021
Q3
$300K Sell
50,600
-71,100
-58% -$999K ﹤0.01% 10603
2021
Q2
$2.12M Sell
121,700
-216,700
-64% -$3.95M ﹤0.01% 5796
2021
Q1
$6.46M Buy
338,400
+306,200
+951% +$5.59M ﹤0.01% 3454
2020
Q4
$564K Buy
+32,200
New +$385K ﹤0.01% 8020

Other funds holding HGEN

Susquehanna International Group's HGEN Position: Q2 2023 in Review

Susquehanna International Group sold out of HUMANIGEN, INC. (HGEN) in Q2 2023, closing a stake of 13,768 shares — an estimated $1.98K sold.

Susquehanna International Group first reported a position in HGEN in Q4 2020 and held it in 10 quarters. The position peaked at $7M in Q2 2021. 38 funds tracked by Wall St. Rank hold HGEN as of Q2 2023.

  • Susquehanna International Group reported no remaining HUMANIGEN, INC. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 13,768 HUMANIGEN, INC. shares in Q2 2023, an estimated $1.98K.
  • Susquehanna International Group first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 10 quarters.
  • Susquehanna International Group's HUMANIGEN, INC. position peaked at $7M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.